GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, APP, CBR1, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, ESR1, FABP3, FABP4, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, MET, MIF, PPARA |
12.2473 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, APP, CES1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, ESR1, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
11.4296 |
[BP] GO:0042221 |
response to chemical
|
ABCB1, ADRA2A, AKR1B1, ALOX15, ALPL, APP, AXL, BCL2, CA2, CA9, CDK6, CES1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, FABP3, FABP4, FLT3, HSD11B2, HSD17B2, IGF1R, KCNH2, KDR, MMP2, MMP9, PPARA, PTAFR, RORC, SLC6A2, SLC6A4, SRC, TERT, TYR |
10.0176 |
[BP] GO:0008152 |
metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, AOX1, APP, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CBR1, CDC25B, CDK6, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, IGF1R, KCNH2, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTAFR, PTPN1, PTPRS, RORC, SLC6A4, SRC, TERT, TNKS, TNKS2, TYR, XDH |
9.6341 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, AKR1B10, ALOX15, ALOX5, AOX1, APP, CA1, CA12, CA2, CA4, CA7, CA9, CBR1, CES1, CES2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, FABP3, FUT7, GBA2, MIF, PIM1, PPARA, PTAFR, TYR, XDH |
9.6341 |
[BP] GO:0033993 |
response to lipid
|
ALPL, AXL, BCL2, CA2, CA9, CDK6, CSNK2A1, CYP1A1, CYP1A2, ESR1, ESRRA, FABP3, FLT3, HSD11B2, HSD17B2, PTAFR, RORC, SLC6A4, SRC, TYR |
8.62206 |
[BP] GO:0065008 |
regulation of biological quality
|
ABCB1, ACHE, ADORA1, ADRA2A, AKR1B1, ALOX15, APP, AURKB, AXL, BCL2, CA12, CA2, CA7, CDK6, CYP19A1, CYP1A1, CYP1B1, ESR1, F3, FABP3, FABP4, FLT3, HSD11B1, HSD11B2, HSD17B1, HSD17B2, KCNH2, KDR, MET, MIF, PPARA, PTAFR, SLC6A2, SLC6A4, SRC, TERT, TNKS, TNKS2, XDH |
8.53266 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, ALPL, APP, AXL, BCL2, CA9, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, FABP3, HSD11B2, HSD17B2, IGF1R, MMP2, MMP9, PPARA, PTAFR, RORC, SLC6A4, SRC, TYR |
8.40779 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX15, ALOX5, CBR1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, MIF |
8.35606 |
[BP] GO:0010033 |
response to organic substance
|
ADRA2A, AKR1B1, ALOX15, ALPL, APP, AXL, BCL2, CA2, CA9, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, FABP3, FABP4, FLT3, HSD11B2, HSD17B2, IGF1R, KDR, MMP2, PPARA, PTAFR, RORC, SLC6A4, SRC, TYR |
8.11973 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX15, ALOX5, CBR1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, MIF |
8.11002 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA1, ADORA3, ADRA2A, AKR1B1, APP, BCL2, CDC25B, CDK6, CSNK2A1, CYP1B1, ESR1, ESRRA, F3, FABP3, FLT3, IGF1R, KDR, MIF, MMP12, MMP2, MMP9, PIM1, PTAFR, SLC6A4, SRC, TERT, XDH |
7.85115 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, BCL2, CYP1A1, CYP1A2, CYP1B1, CYP2A6, TYR |
7.74676 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX15, ALOX5, CBR1, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, FABP3, MIF, PPARA |
7.12206 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, AOX1, APP, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CBR1, CDC25B, CDK6, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, FUT7, GBA2, HSD17B1, HSD17B2, IGF1R, KCNH2, KDR, MET, MIF, MMP1, MMP2, PIM1, PPARA, PTAFR, PTPN1, PTPRS, RORC, SLC6A4, SRC, TERT, TNKS, TNKS2, TYR, XDH |
6.96147 |
[BP] GO:0014070 |
response to organic cyclic compound
|
ALPL, APP, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, FLT3, HSD11B2, PTAFR, RORC, SLC6A4, SRC, TYR |
6.90285 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, ALOX15, ALOX5, CBR1, CES1, CES2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, FABP3, FABP4, FUT7, GBA2, MET, MIF, PPARA |
6.68072 |
[BP] GO:0009725 |
response to hormone
|
ADRA2A, AKR1B1, ALPL, BCL2, CA2, CA9, CSNK2A1, CYP1A2, ESR1, ESRRA, FABP3, FLT3, HSD11B2, PPARA, PTAFR, SLC6A4, SRC |
6.66955 |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
6.6365 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX15, ALOX5, CBR1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, MIF |
6.62109 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADORA1, ADRA2A, AKR1B1, ALOX15, APP, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, IGF1R, KCNH2, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTAFR, PTPN1, RORC, SLC6A4, SRC, TERT, TNKS, TNKS2, XDH |
6.62109 |
[BP] GO:0009719 |
response to endogenous stimulus
|
ADRA2A, AKR1B1, ALPL, APP, BCL2, CA2, CA9, CSNK2A1, CYP1A2, ESR1, ESRRA, FABP3, FLT3, HSD11B2, IGF1R, MMP2, PPARA, PTAFR, SLC6A4, SRC |
6.62109 |
[BP] GO:0032502 |
developmental process
|
ACHE, ADORA1, AKR1B1, ALOX15, ALPL, APP, AURKB, AXL, BCL2, CA2, CA9, CBR1, CDC25B, CDK6, CES1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, ESRRB, FABP4, FLT3, FUT7, GBA2, HSD11B1, HSD17B2, KDR, MET, MIF, MMP2, MMP9, PIM1, PPARA, PTPRS, RORC, SLC6A4, SRC, TERT, TNKS2, TYR |
6.59986 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
ADRA2A, AKR1B1, ALOX15, ALPL, APP, AXL, BCL2, CDK6, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP4, FLT3, IGF1R, KCNH2, KDR, MMP2, MMP9, PTAFR, RORC, SLC6A4, SRC, TERT |
6.58584 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADORA1, ADRA2A, AKR1B1, ALOX15, APP, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, F3, FLT3, KDR, MET, MIF, MMP12, MMP9, PTPN1, SRC, TERT, TNKS, TNKS2, XDH |
6.47334 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADORA1, ADRA2A, AKR1B1, ALOX15, APP, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, F3, FLT3, KDR, MET, MIF, MMP12, MMP9, PTPN1, SRC, TERT, TNKS, TNKS2, XDH |
6.44853 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
ALOX15, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19 |
6.13579 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, ALOX15, APP, AXL, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, FABP4, KDR, MMP9, SRC, TERT |
6.0759 |
[BP] GO:0048518 |
positive regulation of biological process
|
ABCB1, ACHE, ADORA1, ADRA2A, AKR1B1, ALOX15, APP, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, IGF1R, KCNH2, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTAFR, PTPN1, RORC, SLC6A4, SRC, TERT, TNKS, TNKS2, XDH |
6.05269 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
6.02907 |
[BP] GO:0032787 |
None
|
ALOX15, ALOX5, CBR1, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, FABP3, GBA2, MIF, PPARA |
5.93065 |
[BP] GO:0032501 |
multicellular organismal process
|
ADORA1, ADRA2A, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, APP, AXL, BCL2, CYP19A1, CYP1A2, CYP1B1, ESR1, ESRRB, F3, FABP4, HSD11B2, HSD17B2, IGF1R, KCNH2, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTAFR, RORC, SLC6A2, SLC6A4, SRC, TNKS2, TYR |
5.88719 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
ADRA2A, AKR1B1, BCL2, CDC25B, CDK6, CSNK2A1, ESR1, F3, FLT3, IGF1R, KDR, MIF, MMP12, MMP2, MMP9, PIM1, PTAFR, TERT |
5.85413 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, AOX1, APP, AURKB, AXL, BCL2, CBR1, CDC25B, CDK6, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, IGF1R, KCNH2, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, PTPRS, RORC, SRC, TERT, TNKS, TNKS2, TYR, XDH |
5.84308 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, ALOX15, ALOX5, AOX1, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, HSD11B1, HSD11B2, HSD17B1, HSD17B2, TYR, XDH |
5.78974 |
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, AOX1, APP, AURKB, AXL, BCL2, CBR1, CDC25B, CDK6, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, IGF1R, KCNH2, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTAFR, PTPN1, PTPRS, RORC, SRC, TERT, TNKS, TNKS2, TYR, XDH |
5.76507 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA7, CA9 |
5.74686 |
[BP] GO:0050896 |
response to stimulus
|
ABCB1, ACHE, ADORA1, ADORA3, ADRA2A, AKR1B1, ALOX15, ALPL, APP, AURKB, AXL, BCL2, CA2, CA9, CDK6, CES1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, F3, FABP3, FABP4, FLT3, HSD11B2, HSD17B2, IGF1R, KCNH2, KDR, MIF, MMP12, MMP2, MMP9, PPARA, PTAFR, PTPN1, RORC, SLC6A2, SLC6A4, SRC, TERT, TYR |
5.65199 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA1, ADORA3, ADRA2A, APP, BCL2, CDK6, CYP19A1, CYP1B1, F3, IGF1R, KDR, MET, MIF, MMP9, PTAFR, SRC, TERT |
5.53999 |
[BP] GO:0042493 |
response to drug
|
ABCB1, AKR1B1, AXL, BCL2, CA9, CDK6, CYP1A1, CYP1B1, FABP3, HSD11B2, KCNH2, KDR, PTAFR, SLC6A2, SLC6A4, SRC |
5.3872 |
[BP] GO:0071310 |
cellular response to organic substance
|
ADRA2A, AKR1B1, ALOX15, ALPL, APP, AXL, BCL2, CDK6, CYP1A1, CYP1B1, ESR1, FABP4, FLT3, IGF1R, KDR, MMP2, PTAFR, RORC, SLC6A4, SRC |
5.31358 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19 |
5.31032 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADORA1, ADRA2A, AKR1B1, ALOX15, APP, AXL, BCL2, CSNK2A1, CYP1B1, F3, FLT3, KDR, MET, MIF, MMP12, MMP9, PTPN1, SRC, TERT, TNKS, TNKS2, XDH |
5.18091 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA1, ADORA3, ADRA2A, APP, BCL2, CYP19A1, CYP1B1, F3, IGF1R, KDR, MET, MIF, MMP9, PTAFR, SRC, TERT |
5.12922 |
[BP] GO:0051716 |
cellular response to stimulus
|
ADRA2A, AKR1B1, ALOX15, ALPL, APP, AURKB, AXL, BCL2, CA2, CA9, CDK6, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP4, FLT3, IGF1R, KCNH2, KDR, MIF, MMP2, MMP9, PTAFR, PTPN1, RORC, SLC6A4, SRC, TERT |
5.10744 |
[BP] GO:0032879 |
regulation of localization
|
ABCB1, ACHE, ADORA1, ADORA3, ADRA2A, ALOX15, APP, AXL, BCL2, CA2, CA7, CDK6, CSNK2A1, CYP19A1, CYP1B1, F3, IGF1R, KCNH2, KDR, MET, MIF, MMP12, MMP9, PPARA, PTAFR, PTPN1, SLC6A4, SRC, TERT |
5.10744 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA1, ADORA3, ADRA2A, APP, BCL2, CDK6, CYP19A1, CYP1B1, F3, IGF1R, KDR, MET, MIF, MMP9, PTAFR, SRC, TERT |
5.10391 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA1, ADORA3, ADRA2A, APP, BCL2, CDK6, CYP19A1, CYP1B1, F3, IGF1R, KDR, MET, MIF, MMP9, PTAFR, SRC, TERT |
5.08986 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADORA1, ADRA2A, AKR1B1, ALOX15, APP, AXL, BCL2, CSNK2A1, CYP1B1, ESRRA, F3, FABP4, FLT3, KDR, MET, MIF, MMP12, MMP2, MMP9, PTAFR, PTPN1, SRC, TERT, TNKS, TNKS2, XDH |
4.98151 |
[BP] GO:2001225 |
regulation of chloride transport
|
ABCB1, CA2, CA7, PTAFR |
4.91771 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1, CYP2C19 |
4.91771 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, ALOX15, APP, BCL2, CES1, CYP19A1, CYP1A1, CYP1B1, GBA2, PTAFR, TYR |
4.90717 |
[BP] GO:0048513 |
animal organ development
|
ACHE, AXL, BCL2, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, ESR1, ESRRA, ESRRB, FLT3, HSD11B1, HSD17B2, KDR, PPARA, PTPRS, SRC, TYR |
4.84817 |
[BP] GO:0019752 |
carboxylic acid metabolic process
|
ALOX15, ALOX5, CBR1, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, FABP3, GBA2, MIF, PIM1, PPARA, TYR |
4.59715 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
ALOX15, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19 |
4.57046 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADORA1, ADRA2A, AKR1B1, ALOX15, APP, AURKB, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, ESR1, ESR2, F3, FLT3, IGF1R, KDR, MET, MIF, MMP12, MMP9, PTPN1, PTPRS, SLC6A4, SRC, TERT, TNKS, TNKS2, XDH |
4.53769 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
4.5267 |
[BP] GO:0009056 |
catabolic process
|
ACHE, ADORA1, AKR1B10, AOX1, AURKB, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, FABP3, FABP4, FUT7, GBA2, MMP1, MMP12, MMP2, MMP9, SRC, XDH |
4.5105 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADORA1, ADRA2A, AKR1B1, ALOX15, APP, AURKB, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, ESR1, ESR2, F3, FLT3, IGF1R, KDR, MET, MIF, MMP12, MMP9, PTPN1, PTPRS, SLC6A4, SRC, TERT, TNKS, TNKS2, XDH |
4.4294 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ADORA1, ADRA2A, ALOX15, APP, AURKB, BCL2, CDC25B, CSNK2A1, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, IGF1R, KDR, MET, MIF, MMP12, MMP9, PPARA, PTAFR, PTPN1, RORC, SLC6A4, SRC, TERT, TNKS, TNKS2, XDH |
4.38067 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B1, HSD17B2 |
4.37399 |
[BP] GO:0032844 |
regulation of homeostatic process
|
ADORA1, ADRA2A, AURKB, BCL2, CA2, CA7, CDK6, KDR, MIF, SRC, TNKS, TNKS2 |
4.33582 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
BCL2, CA2, CA7 |
4.27896 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ADORA1, ADRA2A, ALOX15, APP, AURKB, BCL2, CDC25B, CSNK2A1, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, IGF1R, KDR, MET, MIF, MMP12, MMP9, PPARA, PTAFR, PTPN1, RORC, SLC6A4, SRC, TERT, TNKS, TNKS2, XDH |
4.27406 |
[BP] GO:0006805 |
xenobiotic metabolic process
|
CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, RORC |
4.24428 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ABCB1, ADORA1, ADRA2A, AKR1B1, ALOX15, APP, AURKB, AXL, BCL2, CDK6, CSNK2A1, CYP19A1, CYP1B1, ESR1, ESR2, ESRRA, F3, FABP4, FLT3, IGF1R, KDR, MET, MIF, MMP12, MMP2, MMP9, PPARA, PTAFR, PTPN1, PTPRS, SRC, TERT, TNKS, TNKS2, XDH |
4.24428 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ADORA1, ADRA2A, ALOX15, APP, AURKB, BCL2, CDC25B, CSNK2A1, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, IGF1R, KDR, MET, MIF, MMP12, MMP9, PPARA, PTAFR, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, XDH |
4.24428 |
[BP] GO:0080134 |
regulation of response to stress
|
ABCB1, ADORA1, ADRA2A, APP, CDK6, CYP19A1, ESR1, F3, FABP4, IGF1R, MET, MIF, MMP12, MMP2, PPARA, PTPN1, PTPRS, SRC, TERT, XDH |
4.22093 |
[BP] GO:0030522 |
intracellular receptor signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PIM1, PPARA, RORC, SRC |
4.15553 |
[BP] GO:0043436 |
oxoacid metabolic process
|
ALOX15, ALOX5, CBR1, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, FABP3, GBA2, MIF, PIM1, PPARA, TYR |
4.1087 |
[BP] GO:0010941 |
regulation of cell death
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, ESR1, F3, FLT3, IGF1R, KDR, MET, MIF, MMP9, PIM1, PPARA, PTPN1, SRC, TERT, XDH |
4.10513 |
[BP] GO:0060548 |
negative regulation of cell death
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, IGF1R, KDR, MET, MIF, MMP9, PIM1, PPARA, PTPN1, SRC, TERT |
4.09988 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADORA1, ADRA2A, AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
4.07445 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA1, ADORA3, ADRA2A, AKR1B1, APP, AURKB, AXL, BCL2, CDK6, CSNK2A1, CYP19A1, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, IGF1R, KCNH2, KDR, MET, MIF, MMP12, MMP9, PIM1, PPARA, PTPN1, PTPRS, RORC, SLC6A4, SRC, TERT, TNKS, TNKS2, XDH |
4.04104 |
[BP] GO:0051050 |
positive regulation of transport
|
ABCB1, ACHE, ADORA1, ADRA2A, APP, AXL, BCL2, CA2, CYP19A1, KCNH2, MIF, MMP12, PTAFR, SLC6A4, SRC, TERT |
4.04104 |
[BP] GO:0006082 |
organic acid metabolic process
|
ALOX15, ALOX5, CBR1, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, FABP3, GBA2, MIF, PIM1, PPARA, TYR |
4.03357 |
[BP] GO:0006694 |
steroid biosynthetic process
|
AKR1B1, CES1, CYP19A1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
4.00503 |
[BP] GO:0043067 |
regulation of programmed cell death
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, ESR1, F3, FLT3, IGF1R, KDR, MET, MIF, MMP9, PIM1, PTPN1, SRC, TERT, XDH |
4.00246 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, ADORA1, AKR1B1, ALOX15, ALPL, APP, AXL, BCL2, CA2, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, ESRRB, FLT3, GBA2, HSD11B1, HSD17B2, KDR, MMP9, PIM1, PPARA, PTPRS, RORC, SRC, TYR |
4.00159 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADORA1, ADRA2A, AKR1B1, ALOX15, APP, AXL, BCL2, CYP1B1, F3, FLT3, KDR, MET, MIF, PTPN1, SRC, XDH |
3.98572 |
[BP] GO:0001666 |
response to hypoxia
|
ADORA1, BCL2, CYP1A1, HSD11B2, MMP2, PPARA, SLC6A4, SRC, TERT |
3.97439 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ADORA1, ADRA2A, ALOX15, APP, AURKB, BCL2, CDC25B, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, IGF1R, KDR, MET, MIF, MMP12, MMP9, PPARA, PTAFR, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, XDH |
3.97066 |
[BP] GO:0043401 |
steroid hormone mediated signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC, SRC |
3.94309 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, IGF1R, KDR, MET, MIF, MMP9, PIM1, PTPN1, SRC, TERT |
3.90638 |
[BP] GO:0044070 |
regulation of anion transport
|
ABCB1, ADORA1, CA2, CA7, MIF, PTAFR |
3.9039 |
[BP] GO:0036293 |
response to decreased oxygen levels
|
ADORA1, BCL2, CYP1A1, HSD11B2, MMP2, PPARA, SLC6A4, SRC, TERT |
3.88468 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
ALPL, APP, CYP1A1, CYP1B1, ESR1, FLT3, PTAFR, RORC, SLC6A4, SRC |
3.86779 |
[BP] GO:0030335 |
positive regulation of cell migration
|
ADRA2A, APP, BCL2, F3, IGF1R, KDR, MET, MMP9, PTAFR, SRC, TERT |
3.86779 |
[BP] GO:0008610 |
lipid biosynthetic process
|
ACHE, AKR1B1, ALOX15, CES1, CSNK2A1, CYP19A1, CYP1A1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, MIF |
3.77429 |
[BP] GO:0043393 |
regulation of protein binding
|
APP, AURKB, BCL2, MET, MMP9, PPARA, SRC, TERT |
3.74245 |
[BP] GO:2000147 |
positive regulation of cell motility
|
ADRA2A, APP, BCL2, F3, IGF1R, KDR, MET, MMP9, PTAFR, SRC, TERT |
3.73189 |
[BP] GO:0032845 |
None
|
ADORA1, ADRA2A, BCL2, MIF, SRC, TNKS, TNKS2 |
3.68671 |
[BP] GO:0051272 |
positive regulation of cellular component movement
|
ADRA2A, APP, BCL2, F3, IGF1R, KDR, MET, MMP9, PTAFR, SRC, TERT |
3.62084 |
[BP] GO:0070482 |
response to oxygen levels
|
ADORA1, BCL2, CYP1A1, HSD11B2, MMP2, PPARA, SLC6A4, SRC, TERT |
3.61289 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ADORA1, ADRA2A, ALOX15, BCL2, CDK6, CYP19A1, ESR1, ESR2, IGF1R, MET, MIF, MMP12, MMP9, PPARA, PTPN1, PTPRS, SRC, TERT, XDH |
3.5733 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, ALOX15, ALPL, APP, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, FLT3, IGF1R, KCNH2, KDR, MET, PIM1, PTAFR, PTPN1, PTPRS, SRC, TNKS, XDH |
3.56304 |
[BP] GO:0006468 |
protein phosphorylation
|
APP, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, FLT3, IGF1R, KCNH2, KDR, MET, PIM1, SRC, TNKS |
3.55899 |
[BP] GO:0042981 |
regulation of apoptotic process
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, ESR1, F3, FLT3, IGF1R, KDR, MIF, MMP9, PIM1, PTPN1, SRC, TERT, XDH |
3.51067 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1, HSD17B2 |
3.51067 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADORA1, ADRA2A, AKR1B1, ALOX15, APP, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, ESR1, F3, FLT3, IGF1R, KDR, MET, MIF, MMP9, PTPN1, SRC, XDH |
3.51067 |
[BP] GO:0040017 |
positive regulation of locomotion
|
ADRA2A, APP, BCL2, F3, IGF1R, KDR, MET, MMP9, PTAFR, SRC, TERT |
3.51067 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
ADORA1, ADORA3, ADRA2A, APP, AXL, BCL2, CA2, CDK6, CYP1B1, ESR1, ESRRA, ESRRB, F3, KCNH2, KDR, MET, MIF, MMP12, MMP9, PIM1, PTAFR, PTPRS, SLC6A4, SRC, TERT, TNKS2, XDH |
3.49296 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA1, ADORA3, ADRA2A, AKR1B1, ALOX15, APP, AURKB, AXL, BCL2, CDK6, CSNK2A1, CYP19A1, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, IGF1R, KCNH2, KDR, MET, MIF, MMP12, MMP9, PIM1, PPARA, PTPN1, PTPRS, RORC, SLC6A4, SRC, TERT, TNKS, TNKS2, XDH |
3.41464 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, ALPL, AXL, BCL2, CES1, CYP1A1, CYP1B1, KDR, SLC6A4, SRC |
3.41448 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADORA1, ADRA2A, ALOX15, APP, BCL2, CDC25B, ESRRB, FABP3, FLT3, KDR, MIF, MMP9, PTAFR, PTPN1, SRC, XDH |
3.41448 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADORA1, ADRA2A, ALOX15, APP, BCL2, CDC25B, ESRRB, FABP3, FLT3, KDR, MIF, MMP9, PTAFR, PTPN1, SRC, XDH |
3.41448 |
[BP] GO:0043269 |
regulation of ion transport
|
ABCB1, ADORA1, ADRA2A, APP, BCL2, CA2, CA7, KCNH2, MIF, MMP9, PTAFR, SLC6A4 |
3.41241 |
[BP] GO:0051049 |
regulation of transport
|
ABCB1, ACHE, ADORA1, ADRA2A, ALOX15, APP, AXL, BCL2, CA2, CA7, CYP19A1, KCNH2, MIF, MMP12, MMP9, PPARA, PTAFR, PTPN1, SLC6A4, SRC, TERT |
3.38857 |
[BP] GO:0034502 |
protein localization to chromosome
|
AURKB, ESR1, TERT, TNKS, TNKS2 |
3.365 |
[BP] GO:0010038 |
response to metal ion
|
ALOX15, APP, BCL2, CA2, CYP1A1, CYP1A2, FABP4, MMP9, TERT |
3.35217 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, IGF1R, KDR, MIF, MMP9, PIM1, PTPN1, SRC, TERT |
3.35217 |
[BP] GO:0009755 |
hormone-mediated signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC, SRC |
3.33902 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, ALOX15, ALPL, APP, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, FLT3, IGF1R, KCNH2, KDR, MET, PIM1, PTAFR, PTPN1, PTPRS, SRC, TNKS, XDH |
3.30186 |
[BP] GO:0015711 |
organic anion transport
|
ABCB1, CA1, CA12, CA14, CA2, CA4, CA7, CA9, FABP3, PPARA |
3.29882 |
[BP] GO:0009628 |
response to abiotic stimulus
|
ADORA1, AKR1B1, APP, AURKB, BCL2, CA2, CYP1A1, HSD11B2, MMP2, PPARA, PTAFR, SLC6A4, SRC, TERT, TYR |
3.26583 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, ADORA1, ADRA2A, BCL2, ESR1, ESR2, IGF1R, MET, MIF, MMP12, MMP9, PTPN1, PTPRS, SLC6A4, SRC, TERT, XDH |
3.25683 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, APP, AXL, CDK6, CYP1B1, ESR1, IGF1R, MMP2, MMP9, PTAFR, RORC, SLC6A4, SRC |
3.24962 |
[BP] GO:0044093 |
positive regulation of molecular function
|
ABCB1, ADORA1, ADRA2A, APP, AURKB, BCL2, CDC25B, ESR1, ESR2, F3, FLT3, MET, MIF, MMP9, PTAFR, PTPN1, SRC, TERT, TNKS, XDH |
3.24851 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, ADORA1, ADRA2A, BCL2, ESR1, ESR2, IGF1R, MET, MIF, MMP12, MMP9, PTPN1, PTPRS, SLC6A4, SRC, TERT, XDH |
3.24759 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA3, ADRA2A, APP, AURKB, CSNK2A1, CYP1B1, ESR1, FABP4, IGF1R, MET, MMP9, PIM1, PPARA, PTPN1, SRC, TNKS |
3.15071 |
[BP] GO:0048869 |
cellular developmental process
|
ACHE, ALPL, APP, AXL, BCL2, CBR1, CDC25B, CDK6, CES1, CYP1A1, ESR1, ESRRB, FABP4, FLT3, FUT7, GBA2, KDR, MET, MIF, MMP2, MMP9, PTPRS, RORC, SRC, TERT |
3.14599 |
[BP] GO:0008283 |
cell proliferation
|
ABCB1, ACHE, AURKB, BCL2, CYP1A1, ESR1, FLT3, MET, MIF, PIM1, SRC, TYR |
3.14599 |
[BP] GO:0051098 |
regulation of binding
|
APP, AURKB, BCL2, MET, MMP9, PPARA, SRC, TERT, TNKS |
3.14521 |
[BP] GO:0016042 |
lipid catabolic process
|
ADORA1, AKR1B10, CYP19A1, CYP1A2, CYP1B1, FABP3, FABP4, GBA2 |
2.99723 |
[BP] GO:0022414 |
reproductive process
|
AKR1B1, ALPL, APP, AXL, BCL2, CDC25B, CYP19A1, CYP1A1, ESR1, ESRRB, HSD11B2, HSD17B2, MMP2, MMP9, PTAFR, SLC6A4, SRC |
2.977 |
[BP] GO:0042592 |
homeostatic process
|
ADORA1, ADRA2A, AKR1B1, APP, AXL, BCL2, CA12, CA2, CA7, ESR1, FABP3, FABP4, FLT3, KCNH2, MET, SRC, TERT |
2.96285 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CSNK2A1, FLT3, IGF1R, KDR, PIM1, SRC |
2.94491 |
[BP] GO:0048661 |
positive regulation of smooth muscle cell proliferation
|
AKR1B1, MMP2, MMP9, PTAFR, TERT |
2.90378 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, AXL, CDK6, CYP1B1, KCNH2, KDR, PTAFR, SRC |
2.88118 |
[BP] GO:0048511 |
rhythmic process
|
AXL, BCL2, CSNK2A1, ESR1, PPARA, RORC, SLC6A4, SRC |
2.86151 |
[BP] GO:0042738 |
exogenous drug catabolic process
|
CYP1A2, CYP2A6, CYP2C19 |
2.85681 |
[BP] GO:0009966 |
regulation of signal transduction
|
ADORA1, ADRA2A, AKR1B1, ALOX15, APP, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, ESR1, ESR2, F3, FLT3, IGF1R, KDR, MET, MIF, MMP12, MMP9, PTPN1, PTPRS, SRC, TERT, TNKS, TNKS2, XDH |
2.82662 |
[BP] GO:0009115 |
None
|
AOX1, XDH |
2.76331 |
[BP] GO:0006703 |
estrogen biosynthetic process
|
CYP19A1, HSD17B1, HSD17B2 |
2.76187 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ADORA1, ADRA2A, ALOX15, APP, BCL2, CDC25B, ESRRB, FABP3, FABP4, FLT3, IGF1R, KDR, MIF, MMP9, PPARA, PTAFR, PTPN1, SRC, XDH |
2.75712 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
ADORA1, ADRA2A, ALOX15, APP, BCL2, CDC25B, ESRRB, FLT3, KDR, MIF, MMP9, PTPN1, SRC, XDH |
2.73499 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ADORA1, ADRA2A, ALOX15, APP, BCL2, CDC25B, ESRRB, FABP3, FABP4, FLT3, IGF1R, KDR, MIF, MMP9, PPARA, PTAFR, PTPN1, SRC, XDH |
2.7127 |
[BP] GO:0048545 |
response to steroid hormone
|
ALPL, BCL2, CA2, FLT3, HSD11B2, PTAFR, SRC |
2.67735 |
[BP] GO:0060065 |
uterus development
|
CYP19A1, ESR1, SRC |
2.67542 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ADORA1, ADRA2A, ALOX15, APP, FLT3, KDR, MIF, PTPN1, SRC, XDH |
2.64621 |
[BP] GO:0016310 |
phosphorylation
|
APP, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, FLT3, IGF1R, KCNH2, KDR, MET, PIM1, SRC, TNKS |
2.64621 |
[BP] GO:0070198 |
None
|
TERT, TNKS, TNKS2 |
2.59151 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, APP, FABP3, FLT3, HSD11B2, IGF1R, MMP2, PPARA, PTAFR, SLC6A4, SRC, TYR |
2.57736 |
[BP] GO:0050730 |
None
|
ADORA1, ADRA2A, APP, FLT3, MIF, PTPN1, SRC |
2.55035 |
[BP] GO:0031960 |
response to corticosteroid
|
ALPL, BCL2, FLT3, HSD11B2, PTAFR, SRC |
2.55002 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, AKR1B10, AOX1, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19 |
2.5418 |
[BP] GO:0001101 |
response to acid chemical
|
AKR1B1, FABP3, HSD17B2, KDR, MMP2, PTAFR, SLC6A4, SRC |
2.53205 |
[BP] GO:0030540 |
female genitalia development
|
AXL, CYP19A1, ESR1 |
2.51854 |
[BP] GO:0009987 |
cellular process
|
ABCB1, ACHE, ADORA1, ADORA3, ADRA2A, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, AOX1, APP, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CBR1, CDC25B, CDK6, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, GBA2, HSD17B1, HSD17B2, IGF1R, KCNH2, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTAFR, PTPN1, PTPRS, RORC, SLC6A2, SLC6A4, SRC, TERT, TNKS, TNKS2, TUBB3, TYR, XDH |
2.51423 |
[BP] GO:2001243 |
negative regulation of intrinsic apoptotic signaling pathway
|
BCL2, MIF, MMP9, PTPN1, SRC |
2.50638 |
[BP] GO:0006367 |
transcription initiation from RNA polymerase II promoter
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
2.4906 |
[BP] GO:0043270 |
None
|
ABCB1, ADORA1, ADRA2A, KCNH2, MIF, PTAFR, SLC6A4 |
2.4906 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ADORA1, ADRA2A, ALOX15, APP, BCL2, CDC25B, ESRRB, FABP4, FLT3, IGF1R, KDR, MIF, MMP9, PPARA, PTPN1, SRC, XDH |
2.4906 |
[BP] GO:1901617 |
organic hydroxy compound biosynthetic process
|
AKR1B1, ALOX15, CES1, CYP19A1, PTAFR, TYR |
2.46869 |
[BP] GO:1904355 |
positive regulation of telomere capping
|
AURKB, TNKS, TNKS2 |
2.45518 |
[BP] GO:0006820 |
anion transport
|
ABCB1, CA1, CA12, CA14, CA2, CA4, CA7, CA9, FABP3, PPARA |
2.45355 |
[BP] GO:0002682 |
regulation of immune system process
|
ADORA1, ALOX15, APP, AXL, BCL2, CA2, CDK6, CYP19A1, ESR1, ESRRA, MIF, MMP12, MMP2, PTAFR, PTPN1, PTPRS, SRC |
2.41397 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
ADRA2A, APP, AXL, BCL2, CA2, CYP1B1, ESRRB, F3, KDR, MET, MIF, MMP12, MMP9, PIM1, PTAFR, SRC, TERT |
2.39454 |
[BP] GO:0016137 |
None
|
AKR1B1, AKR1B10, GBA2 |
2.38568 |
[BP] GO:0046110 |
None
|
AOX1, XDH |
2.37141 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.37141 |
[BP] GO:0010676 |
None
|
ESRRB, PPARA, PTAFR, SRC |
2.36349 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
ADORA1, ADRA2A, ALOX15, APP, BCL2, CDC25B, FLT3, KDR, MIF, MMP9, PTPN1, SRC, XDH |
2.35696 |
[BP] GO:0032210 |
regulation of telomere maintenance via telomerase
|
AURKB, SRC, TNKS, TNKS2 |
2.33811 |
[BP] GO:0050731 |
positive regulation of peptidyl-tyrosine phosphorylation
|
ADORA1, ADRA2A, FLT3, MIF, PTPN1, SRC |
2.33811 |
[BP] GO:0051900 |
regulation of mitochondrial depolarization
|
BCL2, KDR, SRC |
2.33279 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, AXL, BCL2, CYP1B1, MMP9, SRC |
2.32816 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, APP, FABP3, FLT3, HSD11B2, IGF1R, MMP2, PPARA, PTAFR, SLC6A4, SRC, TYR |
2.31759 |
[BP] GO:0006721 |
terpenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2C19 |
2.30823 |
[BP] GO:0042542 |
response to hydrogen peroxide
|
AKR1B1, AXL, BCL2, CYP1B1, SRC |
2.29481 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, AXL, CYP1B1, MMP9, SRC |
2.29481 |
[BP] GO:0071396 |
cellular response to lipid
|
AXL, CDK6, ESR1, FLT3, PTAFR, RORC, SLC6A4, SRC |
2.29023 |
[BP] GO:0035588 |
None
|
ADORA1, ADORA3, PTAFR |
2.28303 |
[BP] GO:0009611 |
response to wounding
|
ACHE, ADORA3, ALOX15, BCL2, CYP1A1, PPARA |
2.27918 |
[BP] GO:0065009 |
regulation of molecular function
|
ABCB1, ADORA1, ADORA3, ADRA2A, APP, AURKB, BCL2, CDC25B, CSNK2A1, CYP1B1, ESR1, ESR2, F3, FABP4, FLT3, IGF1R, MET, MIF, MMP9, PIM1, PPARA, PTAFR, PTPN1, SRC, TERT, TNKS, XDH |
2.27506 |
[BP] GO:0043085 |
positive regulation of catalytic activity
|
ADORA1, ADRA2A, APP, AURKB, BCL2, CDC25B, ESR1, F3, FLT3, MIF, PTAFR, PTPN1, SRC, TERT, TNKS, XDH |
2.27409 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
ADORA1, ADRA2A, CYP1A1, FABP3, FLT3, PPARA, RORC, SRC |
2.24426 |
[BP] GO:0050790 |
regulation of catalytic activity
|
ADORA1, ADORA3, ADRA2A, APP, AURKB, BCL2, CDC25B, CSNK2A1, ESR1, F3, FABP4, FLT3, IGF1R, MIF, MMP9, PTAFR, PTPN1, SRC, TERT, TNKS, XDH |
2.20778 |
[BP] GO:0001503 |
ossification
|
ALOX15, ALPL, BCL2, MMP2, MMP9 |
2.20398 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
ADORA1, ADRA2A, ALOX15, APP, FLT3, IGF1R, KDR, MIF, PTPN1, SRC, XDH |
2.20398 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.20176 |
[BP] GO:0045787 |
positive regulation of cell cycle
|
APP, AURKB, CDC25B, CYP1A1, MIF, SLC6A4, SRC, TERT |
2.18736 |
[BP] GO:0090344 |
None
|
CDK6, MIF, TERT |
2.17903 |
[BP] GO:1904707 |
positive regulation of vascular smooth muscle cell proliferation
|
MMP2, MMP9, TERT |
2.17903 |
[BP] GO:0030520 |
intracellular estrogen receptor signaling pathway
|
ESR1, ESR2, SRC |
2.17903 |
[BP] GO:1904356 |
regulation of telomere maintenance via telomere lengthening
|
AURKB, SRC, TNKS, TNKS2 |
2.17425 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.17425 |
[BP] GO:0051247 |
positive regulation of protein metabolic process
|
ADORA1, ADRA2A, ALOX15, APP, BCL2, CDC25B, CSNK2A1, ESR1, F3, FLT3, KDR, MIF, MMP9, PTAFR, PTPN1, SRC, XDH |
2.17314 |
[BP] GO:0070213 |
None
|
TNKS, TNKS2 |
2.14366 |
[BP] GO:0006145 |
None
|
AOX1, XDH |
2.14366 |
[BP] GO:1901529 |
None
|
ABCB1, PTAFR |
2.14366 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.14366 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.13729 |
[BP] GO:0051047 |
None
|
ACHE, ADORA1, CYP19A1, MIF, MMP12, PTAFR, SLC6A4, SRC |
2.12404 |
[BP] GO:0009891 |
positive regulation of biosynthetic process
|
APP, AURKB, ESR1, ESR2, ESRRA, ESRRB, FABP3, IGF1R, KDR, MET, MMP12, PPARA, PTAFR, RORC, SRC, TERT, TNKS, TNKS2 |
2.12341 |
[BP] GO:0007166 |
cell surface receptor signaling pathway
|
ADORA1, ADORA3, APP, AXL, BCL2, CA1, CSNK2A1, F3, FLT3, IGF1R, KDR, MET, MIF, MMP2, MMP9, PTAFR, PTPN1, SRC, TNKS, TNKS2 |
2.11808 |
[BP] GO:0010675 |
None
|
ESRRB, PPARA, PTAFR, RORC, SRC |
2.1166 |
[BP] GO:0051130 |
positive regulation of cellular component organization
|
ALOX15, APP, AURKB, AXL, BCL2, ESR1, IGF1R, KDR, MET, MMP1, MMP9, SRC, TNKS, TNKS2 |
2.09159 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.09159 |
[BP] GO:2000573 |
positive regulation of DNA biosynthetic process
|
AURKB, SRC, TNKS, TNKS2 |
2.09159 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
AXL, FLT3, IGF1R, KDR, MET, MMP2, MMP9, PTPN1, SRC |
2.09111 |
[BP] GO:0030574 |
collagen catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.0686 |
[BP] GO:0009892 |
negative regulation of metabolic process
|
ADORA1, ADRA2A, APP, AURKB, BCL2, CSNK2A1, ESR1, ESR2, ESRRA, FABP4, IGF1R, KDR, MET, MIF, MMP12, MMP9, PPARA, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, XDH |
2.0685 |
[BP] GO:0010557 |
positive regulation of macromolecule biosynthetic process
|
APP, AURKB, ESR1, ESR2, ESRRA, ESRRB, IGF1R, KDR, MET, MMP12, PPARA, PTAFR, RORC, SRC, TERT, TNKS, TNKS2 |
2.0671 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2C19 |
2.06332 |
[BP] GO:0009968 |
negative regulation of signal transduction
|
ADRA2A, BCL2, ESR1, ESR2, IGF1R, MET, MIF, MMP12, MMP9, PTPN1, PTPRS, SRC, TERT, XDH |
2.05262 |
[BP] GO:0048660 |
regulation of smooth muscle cell proliferation
|
AKR1B1, MMP2, MMP9, PTAFR, TERT |
2.0213 |
[BP] GO:0006352 |
DNA-templated transcription, initiation
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
2.0213 |
[BP] GO:0006950 |
response to stress
|
ACHE, ADORA1, ADORA3, AKR1B1, ALOX15, APP, AXL, BCL2, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, HSD11B2, MIF, MMP2, MMP9, PPARA, PTAFR, PTPN1, SLC6A2, SLC6A4, SRC, TERT |
2.0127 |
[BP] GO:0045913 |
None
|
ESRRB, PPARA, PTAFR, SRC |
2.00694 |
[BP] GO:1904353 |
regulation of telomere capping
|
AURKB, TNKS, TNKS2 |
2.00596 |
[CC] GO:0044432 |
endoplasmic reticulum part
|
APP, BCL2, CES1, CES2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, FLT3, GBA2, HSD11B1, HSD11B2, HSD17B2, PTPN1 |
2.67735 |
[CC] GO:0016020 |
membrane
|
ABCB1, ACHE, ADORA1, ADORA3, ADRA2A, ALOX15, ALOX5, ALPL, APP, AXL, BCL2, CA12, CA14, CA2, CA4, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, ESR1, F3, FLT3, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B2, IGF1R, KCNH2, KDR, MET, MMP2, PIM1, PTAFR, PTPN1, PTPRS, SLC6A2, SLC6A4, SRC, TERT, TNKS, TNKS2, TYR |
2.64225 |
[CC] GO:0044444 |
cytoplasmic part
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, AOX1, APP, AURKB, BCL2, CA1, CA2, CA4, CA7, CBR1, CDC25B, CDK6, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, ESR1, ESR2, FABP3, FABP4, FLT3, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, KCNH2, KDR, MIF, MMP2, MMP9, PIM1, PTAFR, PTPN1, PTPRS, SLC6A4, SRC, TERT, TNKS, TNKS2, TYR, XDH |
2.54114 |
[CC] GO:0009986 |
cell surface
|
ABCB1, ACHE, APP, AXL, CA4, F3, KCNH2, MET, MIF, SLC6A2 |
2.46869 |
[CC] GO:0005886 |
plasma membrane
|
ABCB1, ACHE, ADORA1, ADORA3, ADRA2A, ALOX15, ALPL, APP, AXL, CA12, CA14, CA2, CA4, CA9, CSNK2A1, ESR1, F3, FLT3, GBA2, IGF1R, KCNH2, KDR, MET, MMP2, PIM1, PTAFR, PTPN1, PTPRS, SLC6A2, SLC6A4, SRC, TERT |
2.2926 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX15, ALOX5, AOX1, APP, CA1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, TNKS, TYR, XDH |
15.3897 |
[MF] GO:0003824 |
catalytic activity
|
ABCB1, ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, AOX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CBR1, CDC25B, CDK6, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, F3, FLT3, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, IGF1R, KCNH2, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, PIM1, PTPN1, PTPRS, SRC, TERT, TNKS, TNKS2, TUBB3, TYR, XDH |
12.5375 |
[MF] GO:0043167 |
ion binding
|
ABCB1, ACHE, ALOX15, ALOX5, ALPL, AOX1, APP, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, HSD17B1, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTAFR, PTPN1, PTPRS, RORC, SLC6A2, SLC6A4, SRC, TERT, TNKS, TNKS2, TUBB3, TYR, XDH |
10.4167 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
9.83912 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, ALOX15, ALOX5, AOX1, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, HSD11B1, HSD11B2, HSD17B1, HSD17B2, TYR, XDH |
6.89502 |
[MF] GO:0005506 |
iron ion binding
|
ALOX15, ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, XDH |
6.54221 |
[MF] GO:0008270 |
zinc ion binding
|
CA1, CA12, CA2, CA4, CA7, CA9, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP12, MMP2, MMP9, PPARA, PTPN1, RORC, TNKS |
6.33878 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
6.09054 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AKR1B10, AOX1, CBR1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, XDH |
5.97353 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX15, ALOX5, ALPL, AOX1, APP, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SLC6A2, SLC6A4, TERT, TNKS, TNKS2, TYR, XDH |
5.96371 |
[MF] GO:0046872 |
metal ion binding
|
ALOX15, ALOX5, ALPL, AOX1, APP, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SLC6A2, SLC6A4, TERT, TNKS, TNKS2, TYR, XDH |
5.70179 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
5.31032 |
[MF] GO:0098531 |
transcription factor activity, direct ligand regulated sequence-specific DNA binding
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
5.02762 |
[MF] GO:0004879 |
nuclear receptor activity
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
5.02762 |
[MF] GO:0005496 |
steroid binding
|
ESR1, ESR2, ESRRA, ESRRB, HSD11B2, HSD17B1, RORC |
4.96947 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6 |
4.90717 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, TYR |
4.70679 |
[MF] GO:0003707 |
steroid hormone receptor activity
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
4.59715 |
[MF] GO:0008289 |
lipid binding
|
ALOX15, AXL, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, HSD11B2, HSD17B1, PPARA, PTAFR, RORC |
4.33916 |
[MF] GO:0016616 |
oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
AKR1B1, AKR1B10, CBR1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
4.13686 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, SRC |
3.97609 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19 |
3.86779 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, SRC |
3.79588 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
3.56466 |
[MF] GO:0048037 |
cofactor binding
|
AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, HSD11B2, HSD17B1, SRC, XDH |
3.53657 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, TYR |
3.51067 |
[MF] GO:0033764 |
steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
3.33902 |
[MF] GO:0044877 |
macromolecular complex binding
|
ACHE, ADORA1, ADRA2A, CSNK2A1, ESRRB, FLT3, IGF1R, KDR, MMP12, MMP9, PIM1, PPARA, PTPN1, SLC6A4, SRC |
3.33881 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
3.28232 |
[MF] GO:0016229 |
steroid dehydrogenase activity
|
HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
3.24114 |
[MF] GO:0042802 |
identical protein binding
|
ACHE, ADRA2A, AOX1, APP, BCL2, CSNK2A1, ESR1, ESR2, FLT3, IGF1R, KCNH2, KDR, MET, MIF, MMP9, SLC6A4, TERT, TYR, XDH |
3.11308 |
[MF] GO:0016829 |
lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
3.10822 |
[MF] GO:0032403 |
protein complex binding
|
ACHE, ADORA1, ADRA2A, ESRRB, FLT3, IGF1R, KDR, MMP12, MMP9, PPARA, PTPN1, SLC6A4, SRC |
3.03521 |
[MF] GO:0008395 |
steroid hydroxylase activity
|
CYP19A1, CYP1A1, CYP2A6, CYP2C19 |
2.98211 |
[MF] GO:0019899 |
enzyme binding
|
ADRA2A, APP, AURKB, BCL2, CDC25B, CYP1A1, CYP1A2, CYP2A6, CYP2C19, ESR1, ESR2, ESRRB, F3, KCNH2, MET, MIF, PPARA, PTAFR, PTPN1, SLC6A4, SRC, TNKS2 |
2.92427 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA1, ADORA3, ADRA2A, AXL, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, IGF1R, KCNH2, KDR, MET, PPARA, PTAFR, RORC |
2.91651 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
2.83168 |
[MF] GO:0008144 |
drug binding
|
ABCB1, ACHE, AURKB, AXL, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, FLT3, IGF1R, KDR, MET, PIM1, PPARA, SLC6A4, SRC |
2.78727 |
[MF] GO:0038052 |
RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding
|
ESR1, ESR2 |
2.76331 |
[MF] GO:0003845 |
None
|
HSD11B1, HSD11B2 |
2.76331 |
[MF] GO:0060089 |
molecular transducer activity
|
ADORA1, ADORA3, ADRA2A, AXL, CDK6, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, IGF1R, KCNH2, KDR, MET, PPARA, PTAFR, RORC |
2.67658 |
[MF] GO:0016903 |
None
|
AKR1B1, AKR1B10, AOX1, XDH |
2.5964 |
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, CDK6, CSNK2A1, FLT3, IGF1R, KCNH2, KDR, MET, PIM1, SRC |
2.49981 |
[MF] GO:0005330 |
None
|
SLC6A2, SLC6A4 |
2.37141 |
[MF] GO:0047374 |
None
|
CES1, CES2 |
2.37141 |
[MF] GO:0004872 |
receptor activity
|
ADORA1, ADORA3, ADRA2A, AXL, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, IGF1R, KCNH2, KDR, MET, PPARA, PTAFR, RORC |
2.3507 |
[MF] GO:0009055 |
electron transfer activity
|
AKR1B1, AOX1, CYP19A1, CYP1A2, XDH |
2.29481 |
[MF] GO:0001223 |
transcription coactivator binding
|
ESR1, PPARA, TERT |
2.28303 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.25806 |
[MF] GO:0034056 |
estrogen response element binding
|
ESR1, ESR2 |
2.14366 |
[MF] GO:0032795 |
None
|
ADORA1, ADRA2A |
2.14366 |
[MF] GO:0035586 |
None
|
ADORA1, ADORA3, PTAFR |
2.04986 |